Ishimori Shingo, Kaito Hiroshi, Hara Shigeo, Nakanishi Koichi, Yoshikawa Norishige, Iijima Kazumoto
Department of Pediatrics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo, Kobe, Hyōgo, 6500017, Japan.
Division of Diagnostic Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
CEN Case Rep. 2013 Nov;2(2):194-196. doi: 10.1007/s13730-013-0063-4. Epub 2013 Feb 16.
Thin basement membrane nephropathy (TBMN) with heterozygous COL4A3/COL4A4 mutations is considered to be a cause of benign familial hematuria. The disease has been believed to have excellent prognosis and TBMN in early childhood is rarely associated with nephrotic-range proteinuria. Furthermore, the presence of proteinuria in patients with TBMN is associated with autosomal-dominant Alport syndrome, which has poorer prognosis in later life. We present an infant case of nephrotic-range proteinuria associated with TBMN caused by heterozygous COL4A4 mutation. A previously healthy 3-year-old boy developed microhematuria and nephrotic-range proteinuria. Renal pathology simply revealed thinning of the glomerular basement membrane (GBM) and mutational analysis revealed a novel heterozygous mutation in COL4A4. He was treated with lisinopril for 1.5 years, which resolved his proteinuria and hematuria. At the most recent follow-up at 6.5 years of age, urinalysis and kidney function were completely normal, without requiring medication. However, transient but repeated moderate to nephrotic-range proteinuria and microscopic hematuria occurred in association with other illnesses. This case highlights the spectrum of phenotypes that may be apparent in an infant with TBMN. Thinning of the GBM can cause transient nephrotic-range proteinuria, particularly in the early stages of TBMN.
伴有杂合性COL4A3/COL4A4突变的薄基底膜肾病(TBMN)被认为是良性家族性血尿的一个病因。该病一直被认为预后良好,儿童期早期的TBMN很少与肾病范围蛋白尿相关。此外,TBMN患者出现蛋白尿与常染色体显性遗传性Alport综合征相关,后者在后期生活中预后较差。我们报告1例由杂合性COL4A4突变导致的与TBMN相关的肾病范围蛋白尿的婴儿病例。一名此前健康的3岁男孩出现镜下血尿和肾病范围蛋白尿。肾脏病理仅显示肾小球基底膜(GBM)变薄,突变分析显示COL4A4存在一种新的杂合突变。他接受赖诺普利治疗1.5年。蛋白尿和血尿消失。在6.5岁的最近一次随访中,尿液分析和肾功能完全正常,无需药物治疗。然而,与其他疾病相关出现了短暂但反复的中度至肾病范围蛋白尿和镜下血尿。该病例突出了TBMN婴儿可能出现的一系列表型。GBM变薄可导致短暂的肾病范围蛋白尿,尤其是在TBMN的早期阶段。